These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Comparison of serum prostate specific antigen levels and bone scintigraphy in patients with prostate carcinoma]. Bielickaite J, Zadeikaite R, Jurkiene N, Kiudelis J, Kuprionis G. Medicina (Kaunas); 2003; 39(9):867-71. PubMed ID: 14515049 [Abstract] [Full Text] [Related]
5. Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results. Roudier MP, Vesselle H, True LD, Higano CS, Ott SM, King SH, Vessella RL. Clin Exp Metastasis; 2003; 20(2):171-80. PubMed ID: 12705638 [Abstract] [Full Text] [Related]
6. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer. Moslehi M, Cheki M, Salehi-Marzijarani M, Amuchastegui T, Gholamrezanezhad A. Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119 [Abstract] [Full Text] [Related]
8. Extensive bone metastases in a patient with prostatic adenocarcinoma and normal serum prostate-specific antigen and prostatic acid phosphatase. Yuksel M, Cermik TF, Kaya M, Salan A, Ustun F, Salihoglu YS, Yigitbasi ON, Berkarda S. Clin Nucl Med; 2001 Nov; 26(11):962. PubMed ID: 11595863 [No Abstract] [Full Text] [Related]
9. [Bone scintigraphy and rhenium radioisotope management in the course of metastatic prostatic cancer]. Ostwald E, Sabri O, Cremerius U, Jakse G, Büll U. Nuklearmedizin; 1999 Nov; 38(7):302-5. PubMed ID: 10599071 [Abstract] [Full Text] [Related]
10. [Intraoperative scintigraphic visualization of a single rib metastasis from operated prostatic adenocarcinoma]. Sanjurjo S, Hamida W, Letesson G, Hustinx R, Gillet P, Andrianne R. Prog Urol; 2008 Jun; 18(6):402-5. PubMed ID: 18558331 [Abstract] [Full Text] [Related]
14. [Patterns of bone metastases of carcinoma of the prostate: evaluation using 99mTC-MDP bone scintigraphy]. Matsuda H, Sakashita S, Arakawa M, Koyanagi T. Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1809-13. PubMed ID: 3444173 [No Abstract] [Full Text] [Related]
15. Quantitative bone scintigraphy: usefulness in the survey of patients treated for bone metastasis of prostatic cancer. Grob JC, Lallot C, Methlin G, Bollack C. Eur Urol; 1988 Oct; 15(3-4):193-5. PubMed ID: 3145888 [Abstract] [Full Text] [Related]
16. Peripheral bone metastases in prostate cancer: a rare localization at initial presentation. Reigman HI, Stokkel MP. Clin Nucl Med; 2004 May; 29(5):335-6. PubMed ID: 15069341 [No Abstract] [Full Text] [Related]
17. Is bone scintigraphy necessary in initial staging of prostate cancer patients? Jaukovic L, Adjinovic B, Cerovic S, Joksimovic M, Soldatovic Z. Hell J Nucl Med; 2011 May; 14(2):126-30. PubMed ID: 21761013 [Abstract] [Full Text] [Related]
19. Tc-99m MDP bone scintigraphy in a patient with multicentric osteosarcoma. Cermik TF, Salan A, Firat MF, Berkarda S. Clin Nucl Med; 2003 Jul; 28(7):599-600. PubMed ID: 12819421 [No Abstract] [Full Text] [Related]